Abstract:Since December 2019, the Coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread rapidly around the world, overburdening healthcare systems and creating significant global health concerns. Rapid detection of infected individuals via early diagnostic tests and administration of effective therapy remains vital in pandemic control, and recent advances in the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated proteins (Cas) system may support the development of novel diagnostic and therapeutic approaches. Cas-based SARS-CoV-2 detection methods (FnCAS9 Editor Linked Uniform Detection Assay (FELUDA), DNA endonuclease-targeted CRISPR trans reporter (DETECTR), and Specific High-sensitivity Enzymatic Reporter Unlocking (SHERLOCK)) have been developed for easier handling compared to quantitative polymerase chain reaction (qPCR) assays, with good rapidity, high specificity, and reduced need for complex instrumentation. Cas-CRISPR-derived RNA (Cas-crRNA) complexes have been shown to reduce viral loads in the lungs of infected hamsters, by degrading virus genomes and limiting viral replication in host cells. Viral-host interaction screening platforms have been developed using the CRISPR-based system to identify essential cellular factors involved in pathogenesis, and CRISPR knockout (CRISPRKO) and activation screening results have revealed vital pathways in the life cycle of coronaviruses, including host cell entry receptors (ACE2, DPP4, and ANPEP), proteases involved in spike activation and membrane fusion (cathepsin L (CTSL) and transmembrane protease serine 2 (TMPRSS2)), intracellular traffic control routes for virus uncoating and budding, and membrane recruitment for viral replication. Several novel genes (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, subfamily A, member 4 (SMARCA4), ARIDIA, and KDM6A) have also been identified via systematic data mining analysis as pathogenic factors for severe CoV infection. This review highlights how CRISPR-based systems can be applied to investigate the viral life cycle, detect viral genomes, and develop therapies against SARS-CoV-2 infection.

Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review

Unlocking G‐Quadruplexes as targets and tools against COVID‐19

Whole Genome Identification of Potential G-Quadruplexes and Analysis of the G-Quadruplex Binding Domain for SARS-CoV-2

Inhibition of SARS-CoV-2 replication in cells by G-quadruplex ligands

G-Quadruplex Based Biosensor: A Potential Tool For Sars-Cov-2 Detection

Targeting the RNA G-Quadruplex and Protein Interactome for Antiviral Therapy

Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry

G-Quadruplexes in the Viral Genome: Unlocking Targets for Therapeutic Interventions and Antiviral Strategies

Discovery of G-quadruplex-forming Sequences in SARS-CoV-2.

Methodological Advances of Bioanalysis and Biochemical Targeting of Intracellular G‐quadruplexes

G-Quadruplexes in the Regulation of Viral Gene Expressions and Their Impacts on Controlling Infection

Identification of G-quadruplex DNA sequences in SARS-CoV2

Progress in SARS-CoV-2, Diagnostic and Clinical Treatment of COVID-19

Genomics Functional Analysis and Drug Screening of SARS-CoV-2

RNA G-quadruplex in TMPRSS2 Reduces SARS-CoV-2 Infection

G-Quadruplexes in Neurobiology and Virology: Functional Roles and Potential Therapeutic Approaches

Aptamer‐based Strategies Against SARS‐CoV‐2 Viruses

Aptamers Targeting SARS-COV-2: a Promising Tool to Fight Against COVID-19.

DNA G-Quadruplex in NRP1 Promoter Facilitates SARS-CoV-2 Infection

Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development

SARS-CoV-2 pandemics: An update of CRISPR in diagnosis and host-virus interaction studies